Category

New York City

Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease New York City

Brolucizumab Prevails in Treat-and-Extend Trial of Anti-VEGF Therapy for Eye Disease

NEW YORK CITY -- The monoclonal antibody brolucizumab (Beovu) significantly extended the treatment-free interval without disease activity for neovascular age-related macular degeneration (nAMD), with comparable visual acuity, as compared with aflibercept (Eylea), a randomized trial showed. Almost twice as many patients in the brolucizumab arm had a 12-week treatment-free interval…
bubmag
July 19, 2022
Q&A: ‘Happy Life’ — the living and the dead with playwright Kathy Ng New York City

Q&A: ‘Happy Life’ — the living and the dead with playwright Kathy Ng

Happy life employs magical realism to create an immersive world where audiences are made to contemplate violence against women, what happens after murder, and the bureaucracy of second chances. Prior to the production’s official opening on July 22, SupChina spoke with playwright Ng about her writing process, inspiration, and what…
bubmag
July 19, 2022
IssueWire is Offering a 15% Discount on Press Release Distribution and Magazine Feature from July 18th to 22nd July New York City

IssueWire is Offering a 15% Discount on Press Release Distribution and Magazine Feature from July 18th to 22nd July

Start-ups, entrepreneurs and individuals will be able to obtain press release distribution services at a much lower price on IssueWire with the upcoming sale this July. New York City, New York Jul 18, 2022 (Issuewire.com)  - Globally-renowned press release agency, IssueWire is excited to announce a brand-new sale in the month of…
bubmag
July 18, 2022
A man exonerated in the killing of Malcolm X is suing New York City for $40 million New York City

A man exonerated in the killing of Malcolm X is suing New York City for $40 million

NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media features, and analyze NPR’s traffic. This information is shared with…
bubmag
July 16, 2022